NCT00165256View on ClinicalTrials.gov

Wide Excision Alone As Treatment for Ductal Carcinoma in Situ of the Breast

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

158

Participants

Timeline

Start Date

May 31, 1995

Primary Completion Date

July 31, 2002

Study Completion Date

November 30, 2025

Conditions
Ductal Carcinoma in Situ of the Breast
Interventions
OTHER

Observation

Wide excision of DCIS and a minimum of 1cm histologically negative margin of breast tissue

Trial Locations (2)

02115

Dana-Farber Cancer Institute, Boston

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

Brigham and Women's Hospital

OTHER

collaborator

Massachusetts General Hospital

OTHER

collaborator

Beth Israel Deaconess Medical Center

OTHER

lead

Dana-Farber Cancer Institute

OTHER